Transfer of omega‐3 fatty acids across the blood–brain barrier after dietary supplementation with a docosahexaenoic acid‐rich omega‐3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study

Little is known about the transfer of essential fatty acids (FAs) across the human blood–brain barrier (BBB) in adulthood. In this study, we investigated whether oral supplementation with omega‐3 (n‐3) FAs would change the FA profile of the cerebrospinal fluid (CSF).

[1]  Sarah A. Chau,et al.  Effects of omega-3 fatty acids on cognitive performance: a meta-analysis , 2012, Neurobiology of Aging.

[2]  R. Bazinet,et al.  Rapid de‐esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study , 2011, Journal of neurochemistry.

[3]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[4]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[5]  D. Orešković,et al.  The formation of cerebrospinal fluid: Nearly a hundred years of interpretations and misinterpretations , 2010, Brain Research Reviews.

[6]  R. McNamara.  DHA deficiency and prefrontal cortex neuropathology in recurrent affective disorders. , 2010, The Journal of nutrition.

[7]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[8]  J. Palmblad,et al.  Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? , 2010, Current opinion in clinical nutrition and metabolic care.

[9]  P. Scheltens,et al.  Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial , 2010, Alzheimer's & Dementia.

[10]  F. LaFerla,et al.  Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood–brain barrier: An in situ cerebral perfusion study , 2009, Neurochemistry International.

[11]  J. Lah,et al.  DHA diet reduces AD pathology in young APPswe/PS1ΔE9 transgenic mice: Possible gender effects , 2009, Journal of neuroscience research.

[12]  B. Engelhardt,et al.  The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction , 2009, Seminars in Immunopathology.

[13]  J. Palmblad,et al.  Effects of Omega-3 Fatty Acids on Inflammatory Markers in Cerebrospinal Fluid and Plasma in Alzheimer’s Disease: The OmegAD Study , 2009, Dementia and Geriatric Cognitive Disorders.

[14]  P. Dederen,et al.  DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice , 2009, Neurobiology of Disease.

[15]  F. Calon,et al.  Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. , 2009, Prostaglandins, leukotrienes, and essential fatty acids.

[16]  S. Rapoport.  Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[17]  R. Bazinet,et al.  Regulation of brain polyunsaturated fatty acid uptake and turnover. , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[18]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[19]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[20]  A. Folsom,et al.  Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study. , 2007, The American journal of clinical nutrition.

[21]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[22]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[23]  H. Tanila,et al.  Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice , 2006, Neurobiology of Disease.

[24]  Michio Hashimoto,et al.  Docosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractions. , 2005, Biochimica et biophysica acta.

[25]  D. S. Lin,et al.  Can Prenatal N-3 Fatty Acid Deficiency Be Completely Reversed after Birth? Effects on Retinal and Brain Biochemistry and Visual Function in Rhesus Monkeys , 2005, Pediatric Research.

[26]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[27]  Yoshimi Fujii,et al.  Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. , 2005, The Journal of nutrition.

[28]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[29]  B. Lawlor,et al.  Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study , 2003, British Journal of Nutrition.

[30]  B. Heude,et al.  Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. , 2003, The American journal of clinical nutrition.

[31]  J. Pilitsis,et al.  Quantification of Free Fatty Acids in Human Cerebrospinal Fluid , 2001, Neurochemical Research.

[32]  Y. Denkins,et al.  Retinal and brain accretion of long-chain polyunsaturated fatty acids in developing felines: the effects of corn oil-based maternal diets. , 1997, The American journal of clinical nutrition.

[33]  K. Kristensson,et al.  Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease , 1991, Lipids.

[34]  D. S. Lin,et al.  Effects of Dietary n‐3 Fatty Acids on the Phospholipid Molecular Species of Monkey Brain , 1990, Journal of neurochemistry.

[35]  W. R. Morrison,et al.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL. , 1964, Journal of lipid research.

[36]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[37]  D. Mischoulon,et al.  Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. , 2012, The Journal of clinical psychiatry.

[38]  B. Puig,et al.  Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex. , 2010, Journal of Alzheimer's disease : JAD.